Workshop 1: 

Navigating Systemic Cancer Treatment: Essentials, Administration, and Individualized Care (For internist only)

Moderator:

dr. Bambang Karsono, Sp.PD, K-HOM

Workshop 2:

How to Handle Problems in Cancer Management (Emergency)

Moderator:

dr. Diana Paramita, Sp.PD, K-HOM

Workshop 3:

Molecular and Genetic Testing in Daily Practice

Moderator:

dr. Sugiyono Somoastro, Sp.PD, K-HOM

Workshop 4:

Nursing Workshop

From Assessment to Recovery: Hands-on Wound & Stoma Nursing (For Nurse only)

Topic 1.1

Introduction of Cancer Systemic Therapy

dr. Marthino Robinson, Sp.PD, K-HOM

Topic 2.1

Cancer Associated Thrombosis

dr. Griskalia Christine, Sp.PD, K-HOM

Topic 3.1

Molecular Testing in Solid Tumor

dr. Grace Shalmont, Sp.PA, MPH

Topic 4.1 (08.00-08.30)

Perawatan Luka Kanker

dan Negative Pressure Wound Treatment (NPWT)

Ria Andjarwati SKp.,M.Kep.,Sp.Kep.Onk.,ETN

Topic 4.2 (08.30-09.00)

Perawatan Stoma

Ns. Helen S.Kep., ETN

Discussion (08.30-09.00)

Hands on Workshop (09.15-10.30)

Site Visit Poli Luka

Kanker dan Stoma

Topic 1.2

Preparation and Administration of Systemic Therapy

dr. Jusi Susilawati, Sp.PD, K-HOM

Topic 2.2

Cancer Related Bleeding

dr. Salman Paris Harahap, Sp.PD, K-HOM

Topic 3.2

Genetic Testing in Hematological Malignancies

Dr. dr. Lyana Setiawan Sp.PK, Subsp.Onk.K(K)

Topic 1.3

Systemic Therapy in Special Conditions (Liver, Kidney, Elderly)

dr. Faizal Drissa Hasibuan, Sp.PD, K-HOM, FINASIM

Topic 2.3

Tumor Lysis Syndrome

dr. Hayatun Nufus, Sp.PD, K-HOM

Topic 3.3

Interpretation and Clinical Applications of Genetic Testing Results

dr. Inolyn Panjaitan, Sp.PD, K-HOM

Discussion

Discussion

Discussion

Workshop 5

Diagnostic Procedure in Hematologic Malignancies: Advancing Precision in Blood Cancer Detection

Moderator:

dr. Femiko MN Sitohang, Sp.PD, K-HOM, FINASIM

Workshop 6

How to Handle Problems in Cancer Management

(Case based)

(Non-Emergency)

Moderator:

Dr. dr. Dody Ranuhardy, Sp.PD, K-HOM, MPH, FINASIM

Workshop 7

Turning Clinical Questions to Evidence Based Answers

Moderator:

dr. Nyoto Widyo Astoro, Sp.PD, K-HOM, FINASIM

Workshop 8:

Nursing workshop

Secure Lines, Better Outcomes: CVAD Care in Oncology

(For Nurse only)

Topic 5.1

Mastering Cytomorphology for Accurate Hematologic Malignancy Diagnosis

dr. Hubertus Hosti Hayuanta, Sp.PK, FINACP

Topic 6.1

Practical Management of Cancer Pain

dr. Asrul Harsal, Sp.PD, K-HOM, FINASIM

Topic 7.1

How to Search Current Evidence from Cancer Problems

Siti Rizny Fitriana Saldi, M.Sc

Touring ke Poli Perawatan CVAD

(13.00-13.30)

Chemotherapy Central Venous Access Devices (CVAD): Port/CVC

(13.30-14.00)

Ns. Dewi Handayani, S.Kep., M.Kep., Sp.Kep.Onk.

Perawatan Port/CVC

(14.00-14.30)

Discussion

(14.30-14.45)

Lab/Hands on Phantom

(14.45-16.00)

Ns. Dewi Handayani, S.Kep., M.Kep., Sp.Kep.Onk.

Ns. Handrija, S.Kep

Topic 5.2

Flowcytometry

Dr. dr. Agus Susanto Kosasih, Sp.PK, Subsp.HK(K), Subsp.Onk.K(K), MARS

Topic 6.2

Management of Opioid-Induced Constipation

dr. Alvin Tagor Harahap, Sp.PD, K-HOM, FINASIM

Topic 7.2

How to Interpret Pivotal Cancer Studies

dr. Dimas Priantono, Sp.PD, K-HOM, FINASIM

Topic 5.3

Hands-On Workshop: Bone Marrow Puncture Techniques and Interpretation

dr. Ardhi Rahman Ahani, Sp.PD, K-HOM

Topic 6.3

Management of Dyspneu in Palliative Setting Using Opioid

dr. Edison Yantje Saragih, Sp.PD, K-HOM, FINASIM

Topic 7.3

How to Interpret Real World Data from Cancer Trial

Dr. dr. Andree Kurniawan, Sp.PD,

K-HOM, FINASIM

Discussion

Discussion

Discussion

End

OPENING REMARKS

Chairman of National Congress and Symposium of ROICAM 13, 2026

dr. Eka Widya Khorinal, Sp.PD, K-HOM, MPH, FINASIM

Chairman of ISHMO Jakarta

dr. Ronald Alexander Hukom, MHSc, Sp.PD, K-HOM, FINASIM

Chairman of ISHMO

Dr. dr. Tubagus Djumhana Atmakusuma, Sp.PD, K-HOM

Plenary Lecture

Moderator: Prof. Dr. dr. Arry Harryanto Reksodiputro, SpPD, K-HOM

Co-Moderator: dr. Ardhi Rahman Ahani, Sp.PD, K-HOM

Plenary Lecture 1

Breaking the Myths and Improving Cancer Survivorship in Indonesia

Aryanthi Baramuli Putri, S.H., M.H.

Plenary Lecture 2

The Evolving Landscape of Cellular Therapy: From CAR-T to the Next Generation

Professor William Ying Khee Hwang, MBBS, MMed (Int Med), MRCP (UK), FAMS (Haematology)

Morning Coffee Break

SYMPOSIUM 1

Updated Management of Myeloproliferative Neoplasm: Focused on Essential Thrombocytosis

Moderator: Prof. dr. Abdul Muthalib, Sp.PD, K-HOM

SYMPOSIUM 2

From Evidence to Practice: Clinical Experience in Lung Cancer Treatment

Moderator: Prof. Dr. Dr. dr. Ikhwan Rinaldi, Sp.PD,

K-HOM, S.H, M.Epid, M.Pd.Ked, FACP, FINASIM, FIsQua

Topic 1.1

How to Know The Difference of Primary and Secondary Thrombocytosis

Dr. dr. Lugyanti Sukrisman, Sp.PD, K-HOM

Topic 2.1

Current landscape treatment of NSCLC with positive driver mutation (molecular profiling from liquid biopsy)

dr. Sri Agustini Kurniawati, Sp.PD, K-HOM, FINASIM

Topic 1.2

Interpretation of Bone Marrow Biopsy in Myeloproliferative Neoplasm

Dr. dr. Agnes Stephanie Harahap, Sp.PA(K)

Topic 2.2

Redefining 1st Line Standard in EGFRm advanced NSCLC and Case

Dr. dr. Indra Wijaya, Sp.PD, K-HOM

Topic 1.3

Anagrelide Therapy in Essential Thrombocytosis

Dr. dr. Hilman Tadjoedin, Sp.PD, K-HOM

Topic 2.3

Revolutionizing Small-Cell Lung Cancer Treatment with

Immunotherapy and Case Sharing

dr. Findy Prasetyawaty, Sp.PD, K-HOM

Discussion

Discussion

SYMPOSIUM 3

Advancing Oncology Care: Innovations in Targeted Therapy for B-cell Malignancies

Moderator: Prof. Dr. dr. Arry Harryanto Reksodiputro, Sp.PD, K-HOM

SYMPOSIUM 4

Bridging Science and Therapy: New Horizons in Urothelial and Renal Cell Carcinomas

Moderator: Dr. dr. Tubagus Djumhana Atmakusuma, Sp.PD, K-HOM

Topic 3.1

B-cell Lymphoma Imaging: What Matters for Treatment Decision

Dr. dr. Sahat Basana Romanti Ezer Matondang, Sp.Rad(K)

Topic 4.1

Real World Evidence of Avelumab in Advanced Urothelial Carcinoma: Why Does It Matter?

dr. Trinugroho Heri Fadjari, Sp.PD, K-HOM

Topic 3.2

Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma with Oral Treatment: Real-world Insights

Prof. Dr. Dr. dr. Ikhwan Rinaldi, Sp.PD, K-HOM, S.H, M.Epid, M.Pd.Ked, FACP, FINASIM, FIsQua

Topic 4.2

Case Based - Real World Experience in Clinic: Individual Maintenance Treatment with Avelumab in Urothelial Carcinoma

Dr. Steven Shu-Cheng Wu

Topic 3.3

Advancing Outcomes in Relapsed/Refractory Hodgkin Lymphoma: The Clinical Role and Practical Integration of Brentuximab Vedotin

dr. Anna Mira Lubis, Sp.PD, K-HOM

Topic 4.3

Navigating the Treatment Journey: First-Line Strategies Avelumab + Axitinib for Advanced Renal Cell Carcinoma – (Learning from JR 101)

Dr. dr. Hilman Tadjoedin, Sp.PD, K-HOM

LUNCH SYMPOSIUM

Evolving Antibody Drug Conjugate Strategies and Optimized Targeted Therapies in Metastatic Breast Cancer

Moderator: Prof. dr. Abdul Muthalib, Sp.PD, K-HOM

Topic 1

Redefining HER2+ Treatment: Clinical Impact on Sequencing Trastuzumab Deruxtecan in HER2+ Metastatic Breast Cancer

dr. Trinugroho Heri Fadjari, Sp.PD, K-HOM

Topic 2

Beyond HER2 Amplification: The Role of Trastuzumab Deruxtecan in HR+, HER2-Low/Ultralow Metastatic Breast Cancer

Dr. dr. Jeffry Beta Tenggara, Sp.PD, K-HOM

Topic 3

Targeting the PI3K/AKT/PTEN Pathway: Integration of Capivasertib with Endocrine Therapy in HR+, HER2- Advanced / Metastatic Breast Cancer

dr. Nadia Ayu Mulansari, Sp.PD, K-HOM

SYMPOSIUM 5

Optimizing Oral Chemotherapy Strategies in Metastatic Colorectal Cancer Across the Continuum of Care

Moderator: dr. Ronald Alexander Hukom, MHSc, Sp.PD, K-HOM, FINASIM

SYMPOSIUM 6

Eltrombopag a Thrombopoietin-Receptor Agonist in the Treatment of Thrombocytopenia

Moderator: Prof. dr. Zubairi Djoerban, Sp.PD, K-HOM

Topic 5.1

Treatment Sequencing in Metastatic Colorectal Cancer

dr. Toman Tua Julian L Toruan, Sp.PD, K-HOM

Topic 6.1

Medical Approach to Thrombocytopenia Cases in Adults

dr. Sugiyono Somoastro, Sp.PD, K-HOM

Topic 5.2

The Role of Metastatectomy in Metastatic Colorectal Cancer

Dr. dr. Wifanto Saditya Jeo, Sp.B-KBD

Topic 6.2

Redefining ITP Management: Achieving Sustainable Platelet Response with Eltrombopag

Dr. dr. Jeffry Beta Tenggara, Sp.PD, K-HOM

Topic 5.3

Current Indication of Oral Fluoropyrimidines in Metastatic Colorectal Cancer

dr. Eka Widya Khorinal, Sp.PD, K-HOM, MPH, FINASIM

Topic 6.3

When and How to Start Eltrombopag in Daily Practice

Dr. dr. Andhika Rachman, Sp.PD, K-HOM

SYMPOSIUM 7

Optimising Immunotherapy-Based First-Line Treatment in Driver-Negative Metastatic Non-Small Cell Lung Cancer: Evidence, Rationale, and Case-Based Insights

Moderator: Dr. dr. Tubagus Djumhana Atmakusuma, Sp.PD, K-HOM

SYMPOSIUM 8

Advancing Immunotherapy in Gastrointestinal Malignancies: The Evolving Role of Pembrolizumab Across Gastrointestinal Tumor

Moderator: Prof. Dr. dr. Aru Wisaksono Sudoyo, Sp.PD, K-HOM, FINASIM, FACP

Topic 7.1

Defining the Landscape: Epidemiology and Unmet Needs in Driver-Negative Metastatic Non-Small Cell Lung Cancer in Indonesia

dr. Ruth Vonky Rebecca, Sp.PD, K-HOM

Topic 8.1

Pembrolizumab in MSI-H/dMMR Metastatic Colorectal Cancer: Transforming First-Line Treatment Paradigms

dr. Findy Prasetyawaty, Sp.PD, K-HOM

Topic 7.2

Advancing Treatment Strategies: Rationale and Clinical Application of Dual Immunotherapy in Driver-Negative Metastatic Non-Small Cell Lung Cancer (CheckMate 9LA)

Dr. Azura Rozila Ahmad, MBBCh BAO (Hons), LRCSI LRCPI (Dublin), MRCP (UK), CCT (UK)

Topic 8.2

Changing the Treatment Paradigm in Advanced Gastric and Gastroesophageal Junction Cancer with Pembrolizumab

dr. Ralph Girson Gunarsa, Sp.PD, K-HOM, FINASIM

Expert Panel Discussion and Q&A

ID case (Challenging Scenario, e.g., Driver-Negative / irAE Considerations & Joint faculty discussion

Dr. Azura Rozila Ahmad, MBBCh BAO (Hons), LRCSI LRCPI (Dublin), MRCP (UK), CCT (UK)

dr. Ruth Vonky Rebecca, Sp.PD, K-HOM

Discussion

MORNING SYMPOSIUM

Advancing Care in Multiple Myeloma and CLL: Established Evidence, Evolving Outcomes for the Internist

Moderator: Dr. dr. Lugyanti Sukrisman, Sp.PD, K-HOM

MORNING SYMPOSIUM

Getting Life Back After Cancer: Survivorship of Young Patients

Moderator: dr. Marthin Batubara, Sp.PD, K-HOM

Co-Moderator: dr. Devi Astri Rivera Amelia, Sp.PD, K-HOM

Topic 1

Redefining Frontline Myeloma Care: Daratumumab-Based Quadruplets Across Transplant-Eligible and -Ineligible Patients

dr. Ruth Vonky Rebecca, Sp.PD, K-HOM

Topic 1

The Long Shadow of Cancer Treatment: Surveillance of Delayed Toxicities

Dr. dr. Rahmat Cahyanur, Sp.PD, K-HOM

Topic 2

A Decade of Proven Outcomes in CLL: The Long-Term Ibrutinib Evidence and Why Maturity of Data Matters

dr. Sri Agustini Kurniawati, Sp.PD, K-HOM, FINASIM

Topic 2

Fertility After Cancer: Risk and Success

Dr. dr. Kanadi Sumapradja, Sp.OG (K) Fer, M.Sc

SYMPOSIUM 9

A Holistic Approach to HR+/HER2- Breast Cancer Care

Moderator: Prof. dr. Zubairi Djoerban, Sp.PD, K-HOM

Co-Moderator: dr. Faisal Syarifuddin, Sp.PD, K-HOM

SYMPOSIUM 10

Checkpoint Evolution: Immunotherapy Strategies in Advanced Non-Small Cell Lung Cancer

Moderator: Prof. Dr. Dr. dr. Ikhwan Rinaldi, Sp.PD, K-HOM, S.H, M.Epid, M.Pd.Ked, FACP, FINASIM, FIsQua

Topic 9.1

Prognostic Stratification of Oestrogen Receptor-positive HER2-negative Breast Cancer

dr. Hartono Tjahjadi, Sp.PA, Subsp. O.G.P.(K)

Topic 10.1

Molecular Testing in Advanced Non-Small Cell Lung Cancer

Ahmad Rusdan Handoyo Utomo, PhD

Topic 9.2

Uncovering the Risk of Recurrence in Early Breast Cancer

Dr. dr. Andhika Rachman, Sp.PD, K-HOM

Topic 10.2

Immunotherapy for Advanced Squamous Non-Small Cell Lung Cancer: Translating Clinical Evidence into Real-World Practice

Dr. dr. Cosphiadi Irawan, Sp.PD, K-HOM

Topic 9.3

From Evidence to Practice: CDK4/6 Inhibition in Early Breast Cancer

dr. Ralph Girson Manuel, Sp.PD, K-HOM

Topic 10.3

Immunotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: Integrating Clinical Evidence with the Challenge

Dr. dr. Wulyo Rajabto, Sp.PD, K-HOM

SYMPOSIUM 11

Redefining Success in Breast Cancer: From Survival to Quality of Life

Moderator: dr. Asrul Harsal, Sp.PD, K-HOM, FINASIM

SYMPOSIUM 12

Comprehensive management of ALK+ Non-Small Cell Lung Cancer

Moderator: Prof. Dr. dr. Noorwati Sutandyo, Sp.PD, K-HOM

Topic 11.1

Abemaciclib From Months to Years: A New Survival Narrative in Breast Cancer

dr. Anna Mira Lubis, Sp.PD, K-HOM

Topic 12.1

Current Management of ALK Positive Metastatic Non-Small Cell Lung Cancer

Dr. dr. Wulyo Rajabto, Sp.PD, K-HOM

Topic 11.2

If The Tumor Responds but The Bone Breaks—Did We Really Win?

dr. Santi Gultom, Sp.PD, K-HOM

Topic 12.2

Changing Expectations in ALK+ Non-Small Cell Lung Cancer: Insights from the CROWN 7-Year Data

Dr. Kenneth Sooi Wei Xiong MBBS, MRCP (UK), M.Med (Int Med)

Topic 11.3

Beyond Symptom Relief: Redefining Success in Chemotherapy-induced Nausea and Vomiting

dr. Nia Novianti Siregar, Sp.PD, K-HOM

Topic 12.3

Do ambulatory Lung Cancer Patients need Anticoagulant Prophylaxis?

dr. Diah Ari Safitri, Sp.PD, K-HOM

HOST-Q Final Round*

(Hematology and Medical Oncology Smart Quiz)

Sambutan dari Ketua PERHOMPEDIN Cab. Jakarta

dr. Ronald Alexander Hukom, MHSc, Sp.PD, K-HOM

Scientific Session

Moderator: dr. Ronald Alexander Hukom, MHSc, Sp.PD, K-HOM

Scientific Session I:

Cancer-Related Fatigue: From Pathophysiology to Practical Management

Prof. Dr. dr. Noorwati Sutandyo, Sp.PD, K-HOM

Scientific Session II:

AHCC in Oncology: Translating Immunonutrition into Evidence-Based Clinical Practice

Toshiya Kamiyama, MD, FACS

Public Seminar Session I

Moderator: dr. Eka Widya Khorinal, Sp.PD, K-HOM, MPH, FINASIM

Topic 1

Pink Path: Mengurai Perjalanan Pasien Kanker Payudara dan Tantangannya

dr. Martha Iskandar, Sp.PD, K-HOM, FINASIM

Topic 2

Tatalaksana Manajemen Kanker Payudara

dr. Ni Putu Merlynda Pusvita Dewi, Sp.PD, K-HOM

Public Seminar Session II

Akses & Pembiayaan Kanker Payudara di Jalur Layanan Swasta

Moderator: Prof. Dr. dr. Aru Wisaksono Sudoyo, Sp.PD, K-HOM, FINASIM, FACP

Topic 3

Tantangan dalam Mengakses Layanan Pasien Kanker Payudara

dr. Prasetyo Widhi Buwono, Sp.PD, K-HOM

Topic 4

Menjawab Tantangan Akses dan Pembiayaan Layanan Kanker Payudara

Bapak Yosie William Iroth (Prudential)